Moncrieff, J, Leo, J. A systematic review of the effects of antipsychotic drugs on brain volume. Psychol Med
2010; 40: 1409–22.
Olabi, B, Ellison-Wright, I, McIntosh, AM, Wood, SJ, Bullmore, E, Lawrie, SM. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiatry
2011; 70: 88–96.
Vita, A, De Peri, L, Deste, G, Barlati, S, Sacchetti, E. The effect of antipsychotic treatment on cortical gray matter changes in schizophrenia: does the class matter? A meta-analysis and meta-regression of longitudinal magnetic resonance imaging studies. Biol Psychiatry
2015; 78: 403–12.
Bodnar, M, Malla, AK, Czechowska, Y, Benoit, A, Fathalli, F, Joober, R, et al. Neural markers of remission in first-episode schizophrenia: a volumetric neuroimaging study of the hippocampus and amygdala. Schizophr Res
2010; 122: 72–80.
Lieberman, J, Chakos, M, Wu, H, Alvir, J, Hoffman, E, Robinson, D, et al. Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry
2001; 49: 487–99.
Bervoets, C, Morrens, M, Vansteelandt, K, Kok, F, de Patoul, A, Halkin, V, et al. Effect of aripiprazole on verbal memory and fluency in schizophrenic patients: results from the ESCAPE study. CNS Drugs
2012; 26: 975–82.
Kern, RS, Green, MF, Cornblatt, BA, Owen, JR, McQuade, RD, Carson, WH, et al. The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine. Psychopharmacology
2006; 187: 312–20.
Riedel, M, Spellmann, I, Schennach-Wolff, R, Musil, R, Dehning, S, Cerovecki, A, et al. Effect of aripiprazole on cognition in the treatment of patients with schizophrenia. Pharmacopsychiatry
2010; 43: 50–7.
First, MB, Gibbon, M, Spitzer, RL, Williams, JBW, Benjamin, LS. Structured Clinical Interview for DSM-IV Axis I Disorders, Research DVersion, Patient VEdition.
American Psychiatric Press, 1997.
Iyer, S, Jordan, G, MacDonald, K, Joober, R, Malla, A. Early intervention for psychosis: a Canadian perspective. J Nerv Ment Dis.
2015; 203: 356–64.
Woods, SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry
2003; 64: 663–7.
Hollingshead, A. Two-Factor Index of Social Position.
Yale University Press, 1965.
Oldfield, RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychology
1971; 9: 97–113.
Wechsler, D. Wecshler Adult Intelligence Scale (3rd edn). The Psychological Corporation, 1997.
Wechsler, D. Wechsler Abbreviated Scale of Intelligence.
The Psychological Corporation, 1999.
Malla, AK, Norman, RM, Manchanda, R, Townsend, L. Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis. Psychol Med
2002; 32: 1109–19.
Malla, A, Norman, R, Schmitz, N, Manchanda, R, Bechard-Evans, L, Takhar, J, et al. Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychol Med
2006; 36: 649–58.
Andreasen, NC. Scale for the Assessment of Positive Symptoms (SAPS).
University of Iowa, 1984.
Andreasen, NC. Modified Scale for the Assessment of Negative Symptoms (SANS).
University of Iowa, 1984.
Andreasen, NC, Carpenter, WT Jr, Kane, JM, Lasser, RA, Marder, SR, Weinberger, DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry
2005; 162: 441–9.
Van Leemput, K, Bakkour, A, Benner, T, Wiggins, G, Wald, LL, Augustinack, J, et al. Automated segmentation of hippocampal subfields from ultra-high resolution in vivo MRI. Hippocampus
2009; 19: 549–57.
Reuter, M, Fischl, B. Avoiding asymmetry-induced bias in longitudinal image processing. NeuroImage
2011; 57: 19–21.
Reuter, M, Schmansky, NJ, Rosas, HD, Fischl, B. Within-subject template estimation for unbiased longitudinal image analysis. NeuroImage
2012; 61: 1402–18.
Chakravarty, MM, Steadman, P, van Eede, MC, Calcott, RD, Gu, V, Shaw, P, et al. Performing label-fusion-based segmentation using multiple automatically generated templates. Hum Brain Mapp
2013; 34: 2635–54.
Winterburn, JL, Pruessner, JC, Chavez, S, Schira, MM, Lobaugh, NJ, Voineskos, AN, et al. A novel in vivo atlas of human hippocampal subfields using high-resolution 3 T magnetic resonance imaging. NeuroImage
2013; 74: 254–65.
Pipitone, J, Park, MT, Winterburn, J, Lett, TA, Lerch, JP, Pruessner, JC, et al. Multi-atlas segmentation of the whole hippocampus and subfields using multiple automatically generated templates. NeuroImage
2014; 101: 494–512.
Lieberman, JA, Stroup, TS, McEvoy, JP, Swartz, MS, Rosenheck, RA, Perkins, DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med
2005; 353: 1209–23.
Stip, E, Anselmo, K. Effectiveness of antipsychotics: is the CATIE trial a tsunami?
Can Fam Physician
2007; 53: 97–8.
Cassidy, CM, Rabinovitch, M, Schmitz, N, Joober, R, Malla, A. A comparison study of multiple measures of adherence to antipsychotic medication in first-episode psychosis. J Clin Psychopharmacol
2010; 30: 64–7.
Fu, DJ, Bossie, CA, Sliwa, JK, Ma, YW, Alphs, L. Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison. Int Clin Psychopharmacol
2014; 29: 45–55.
Spalding, KL, Bergmann, O, Alkass, K, Bernard, S, Salehpour, M, Huttner, HB, et al. Dynamics of hippocampal neurogenesis in adult humans. Cell
2013; 153: 1219–27.
Deng, W, Aimone, JB, Gage, FH. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?
Nat Rev Neurosci
2010; 11: 339–50.
Russo, E, Citraro, R, Davoli, A, Gallelli, L, Di Paola, ED, De Sarro, G. Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity. Neuropharmacology
2013; 64: 371–9.
Nagai, T, Murai, R, Matsui, K, Kamei, H, Noda, Y, Furukawa, H, et al. Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors. Psychopharmacology
2009; 202: 315–28.
Nowakowska, E, Kus, K, Ratajczak, P, Cichocki, M, Wozniak, A. The influence of aripiprazole, olanzapine and enriched environment on depressant-like behavior, spatial memory dysfunction and hippocampal level of BDNF in prenatally stressed rats. Pharmacol Rep
2014; 66: 404–11.
Li, Z, Ichikawa, J, Dai, J, Meltzer, HY. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain. Eur J Pharmacol
2004; 493: 75–83.
Yoneyama, M, Hasebe, S, Kawamoto, N, Shiba, T, Yamaguchi, T, Kikuta, M, et al. Beneficial in vivo effect of aripiprazole on neuronal regeneration following neuronal loss in the dentate gyrus: evaluation using a mouse model of trimethyltin-induced neuronal loss/self-repair in the dentate gyrus. J Pharmacol Sci
2014; 124: 99–111.
Schlagenhauf, F, Dinges, M, Beck, A, Wustenberg, T, Friedel, E, Dembler, T, et al. Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation. Schizophr Res
2010; 118: 189–200.
Schreiber, R, Newman-Tancredi, A. Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT(1A) receptor activation. Neurobiol Learn Memory
2014; 110: 72–80.
Halim, ND, Weickert, CS, McClintock, BW, Weinberger, DR, Lipska, BK. Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus. Neuropsychopharmacology
2004; 29: 1063–9.
Chen, BH, Yan, BC, Park, JH, Ahn, JH, Lee, DH, Kim, IH, et al. Aripiprazole, an atypical antipsychotic drug, improves maturation and complexity of neuroblast dendrites in the mouse dentate gyrus via increasing superoxide dismutases. Neurochem Res
2013; 38: 1980–8.
Maeda, K, Sugino, H, Hirose, T, Kitagawa, H, Nagai, T, Mizoguchi, H, et al. Clozapine prevents a decrease in neurogenesis in mice repeatedly treated with phencyclidine. J Pharmacol Sci
2007; 103: 299–308.
Gao, J, Qin, R, Li, M. Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function. J Psychopharmacol
2015; 29: 390–400.
Egan, MF, Kojima, M, Callicott, JH, Goldberg, TE, Kolachana, BS, Bertolino, A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell
2003; 112: 257–69.
Park, SW, Lee, JG, Ha, EK, Choi, SM, Cho, HY, Seo, MK, et al. Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells. Eur Neuropsychopharmacol
2009; 19: 356–62.
Binder, DK, Scharfman, HE. Brain-derived neurotrophic factor. Growth Factors
2004; 22: 123–31.
Kuhn, S, Musso, F, Mobascher, A, Warbrick, T, Winterer, G, Gallinat, J. Hippocampal subfields predict positive symptoms in schizophrenia: first evidence from brain morphometry. Transl Psychiatry
2012; 2: e127.
Mathew, I, Gardin, TM, Tandon, N, Eack, S, Francis, AN, Seidman, LJ, et al. Medial temporal lobe structures and hippocampal subfields in psychotic disorders: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. JAMA Psychiatry
2014; 71: 769–77.
Kawano, M, Sawada, K, Shimodera, S, Ogawa, Y, Kariya, S, Lang, DJ, et al. Hippocampal subfield volumes in first episode and chronic schizophrenia. PLoS One
2015; 10: e0117785.
Wisse, LE, Biessels, GJ, Geerlings, MI. A critical appraisal of the hippocampal subfield segmentation package in freeSurfer. Front Aging Neurosci
2014; 6: 261.